UnitedHealth Group Stock Undervalued Despite Recent Setbacks

UnitedHealth Group's (UNH) stock has performed well over the past year, returning 30.3%. However, despite this strong performance, the company's valuation metrics suggest it may be undervalued.

The P/E ratio is a useful tool for gauging what investors are paying for each dollar of earnings. UnitedHealth Group currently trades on a P/E of 24.5x, which is slightly below the broader Healthcare sector average of 25.3x and the peer average of 28.8x.

On Simply Wall St's 'fair' P/E ratio, which factors in the company profile and risk mix, UnitedHealth Group's current multiple sits well under this fair level. This suggests that the market is pricing the stock below both sector benchmarks and its modelled fair valuation.